Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
84.82B | 79.06B | 65.50B | 55.39B | 56.00B | Gross Profit |
84.82B | 81.25B | 65.50B | 55.39B | 56.00B | EBIT |
0.00 | 57.43B | 71.75B | 32.79B | 24.08B | EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
45.77B | 39.48B | 33.36B | 25.33B | 19.85B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
147.94B | 335.58B | 309.99B | 400.72B | 373.01B | Total Assets |
3.61T | 3.44T | 3.24T | 2.92T | 2.92T | Total Debt |
0.00 | 952.37B | 838.67B | 778.50B | 824.50B | Net Debt |
-147.94B | 620.96B | 528.69B | 481.77B | 540.98B | Total Liabilities |
3.33T | 3.17T | 2.98T | 2.68T | 2.67T | Stockholders Equity |
283.11B | 269.13B | 258.87B | 243.65B | 248.28B |
Cash Flow | Free Cash Flow | |||
-159.12B | 43.00M | 32.80B | 37.10B | 80.74B | Operating Cash Flow |
-156.44B | 4.12B | 36.31B | 41.59B | 84.57B | Investing Cash Flow |
-880.00M | -1.76B | -7.65B | -4.39B | -4.72B | Financing Cash Flow |
-29.57B | 14.18B | 34.25B | -15.74B | -102.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $639.44B | 11.58 | 17.28% | 2.10% | 17.07% | 21.78% | |
75 Outperform | $158.89B | 12.61 | 11.95% | 2.30% | 14.80% | 77.97% | |
75 Outperform | $39.40B | 9.61 | 17.21% | 4.18% | 17.01% | 16.07% | |
71 Outperform | $214.42B | 12.24 | 10.81% | 2.36% | 7.87% | 11.69% | |
70 Neutral | $283.05B | 11.58 | 9.24% | 2.74% | 13.06% | 4.94% | |
66 Neutral | $118.67B | 10.61 | 6.04% | 3.50% | 8.20% | 49.26% | |
63 Neutral | $14.39B | 9.81 | 8.95% | 4.37% | 16.38% | -11.64% |